Page last updated: 2024-08-24

protolichesterinic acid and Pancreatic Neoplasms

protolichesterinic acid has been researched along with Pancreatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Becker, S; Bessadóttir, M; Eiríksson, FF; Ögmundsdóttir, HM; Ögmundsdóttir, MH; Ómarsdóttir, S; Thorsteinsdóttir, M	1

Other Studies

1 other study(ies) available for protolichesterinic acid and Pancreatic Neoplasms

Article	Year
Anti-proliferative and pro-apoptotic effects of lichen-derived compound protolichesterinic acid are not mediated by its lipoxygenase-inhibitory activity. Prostaglandins, leukotrienes, and essential fatty acids, 2015, Volume: 98 Topics: 4-Butyrolactone; Apoptosis; Arachidonate 12-Lipoxygenase; Arachidonate 5-Lipoxygenase; Cell Line, Tumor; Cell Proliferation; Cytoplasm; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Lichens; Multiple Myeloma; Pancreatic Neoplasms	2015

Article

Year

Anti-proliferative and pro-apoptotic effects of lichen-derived compound protolichesterinic acid are not mediated by its lipoxygenase-inhibitory activity.

Prostaglandins, leukotrienes, and essential fatty acids, 2015, Volume: 98

Topics: 4-Butyrolactone; Apoptosis; Arachidonate 12-Lipoxygenase; Arachidonate 5-Lipoxygenase; Cell Line, Tumor; Cell Proliferation; Cytoplasm; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Lichens; Multiple Myeloma; Pancreatic Neoplasms

2015